P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3
Xavier Leleu,
Noopur Raje,
Alexander Lesokhin,
Mohamad Mohty,
Ajay Nooka,
Eric Leip,
Sharon T. Sullivan,
Andrea Viqueira,
Salomon Manier
Affiliations
Xavier Leleu
1 CHU de Poitiers, Hôpital de la Milétrie, Pôle Régional de Cancérologie, Poitiers, France
Noopur Raje
2 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
Alexander Lesokhin
3 Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States
Mohamad Mohty
4 Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
Ajay Nooka
5 Winship Cancer Institute, Atlanta, United States
